Skip to main content
SpringerLink
Log in

A permissive role of growth hormone (GH) in the development of second brain tumors after radiotherapy?

  • Research Letter
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. P. Burman, A.P. van Beek, B.M.K. Biller, C. Camacho-Hübner, A.F. Mattsson, Radiotherapy, especially at young age, increases the risk for de novo brain tumors in patients treated for pituitary/sellar lesions. J. Clin. Endocrinol. Metab. 102(3), 1051–1058 (2017)

    PubMed  Google Scholar 

  2. M.S. Pearce, J.A. Salotti, M.P. Little, K. McHugh, C. Lee, K.P. Kim, N.L. Howe, C.M. Ronckers, P. Rajaraman, A.W. Sir Craft, L. Parker, A. Berrington de González, Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 380(9840), 499–505 (2012)

    Article  PubMed  PubMed Central  Google Scholar 

  3. J.D. Mathews, A.V. Forsythe, Z. Brady, M.W. Butler, S.K. Goergen, G.B. Byrnes, G.G. Giles, A.B. Wallace, P.R. Anderson, T.A. Guiver, P. McGale, T.M. Cain, J.G. Dowty, A.C. Bickerstaffe, S.C. Darby, Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ 346, f2360 (2013)

    Article  PubMed  PubMed Central  Google Scholar 

  4. R.W. Tsang, N.J. Laperriere, W.J. Simpson, J. Brierley, T. Panzarella, H.S. Smyth, Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk. Cancer 72(7), 2227–2233 (1993)

    Article  CAS  PubMed  Google Scholar 

  5. L. Norberg, R. Johansson, T. Rasmuson, Intracranial tumours after external fractionated radiotherapy for pituitary adenomas in northern Sweden. Acta. Oncol. 49(8), 1276–1282 (2010)

    Article  PubMed  Google Scholar 

  6. M.G. Sattler, A.P. van Beek, B.H. Wolffenbuttel, G. van den Berg, W.J. Sluiter, J.A. Langendijk, A.C. van den Bergh, The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone. Radiother. Oncol. 104(1), 125–130 (2012)

    Article  PubMed  Google Scholar 

  7. C. Boguszewski, M.C. da Silva Boguszweski, J.J. Kopchick, Growth hormone, insulin-like growth factor system, and carcinogenesis. Endokrynol. Pol. 67(4), 414–426 (2016)

    PubMed  Google Scholar 

  8. I.E. McCutcheon, A. Flyvbjerg, H. Hill, J. Li, W.F. Bennett, J.A. Scarlett, K.E. Friend, Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice. J. Neurosurg. 94(3), 487–492 (2001)

    Article  CAS  PubMed  Google Scholar 

  9. C.L. Boguszewski, J. Ayuk, Management of endocrine disease: acromegaly and cancer: an old debate revisited. Eur. J. Endocrinol. 175(4), R147–R1456 (2016)

    Article  PubMed  Google Scholar 

  10. J. Honegger, M. Buchfelder, U. Schrell, E.F. Adams, R. Fahlbusch, The coexistence of pituitary adenomas and meningiomas: three case reports and a review of the literature. Br. J. Neurosurg. 3(1), 59–69 (1989)

    Article  CAS  PubMed  Google Scholar 

  11. K. Rothkamm, M. Lobrich, Evidence for a lack of DNA double-strand break repair in human cells exposed to very low X-ray doses. Proc. Natl. Acad. Sci. USA. 100(9), 5057–5062 (2003)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. T.M. Pawlik, K. Keyomarsi, Role of cell cycle in mediating sensitivity to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 59(4), 928–942 (2004)

    Article  PubMed  Google Scholar 

  13. V. Chesnokova, S. Zonis, C. Zhou, M.V. Recouvreux, A. Ben-Shlomo, T. Araki, R. Barett, M. Workman, K. Wawrowsky, V.A. Ljubimov, M. Uhart, S. Melmed, Growth hormone is permissive for neoplastic colon growth. Proc. Natl. Acad. Sci. USA. 113(23), E3250–E3259 (2016)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Skane University Hospital, University of Lund, 205 02, Malmö, Sweden

    Pia Burman

  2. Departments of Clinical Epidemiology and Endocrinology, Leiden University Medical Centre, Leiden, The Netherlands

    Olaf M. Dekkers

Authors
  1. Pia Burman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Olaf M. Dekkers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pia Burman.

Ethics declarations

Conflict of interest

The authors declares that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Burman, P., Dekkers, O.M. A permissive role of growth hormone (GH) in the development of second brain tumors after radiotherapy?. Endocrine 57, 356–358 (2017). https://doi.org/10.1007/s12020-017-1325-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-017-1325-2

Keywords

Search

Navigation